BioRestorative Therapies, Inc.
USD0.38
+0.01 (+1.62%)
CEO
Lance Alstodt
IPO Date
2012-12-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.36
Prev. Close
$0.37
Day Low
$0.35
Day High
$0.38
52W Low
$0.16
52W High
$1.89
Market Cap
$0.00B
Volume
0.61M
| -1.2 |
| 31 Dec 2023 | FY | 100.0% | -7145.2% | -104.1% | -82.6% | 0.02 | 4.37 | -0.7 |
| 31 Dec 2022 | FY | 100.0% | -11037.0% | -128.5% | -80.5% | 0.03 | 2.53 | -0.8 |
| 31 Dec 2021 | FY | 100.0% | -96311.5% | -205.1% | -197.3% | 0.03 | 59.01 | -0.1 |
| 31 Dec 2020 | FY | 100.0% | -14639.9% | 846.6% | -259.3% | -3.60 | 3.05 | -1.0 |
| 31 Dec 2019 | FY | 100.0% | -11267.6% | 114.7% | -999.0% | -0.61 | 0.01 | -0.0 |
| 31 Dec 2018 | FY | 100.0% | -11277.3% | 144.9% | -1049.8% | -0.48 | 0.02 | -0.8 |
| 31 Dec 2017 | FY | -220.1% | -11660.1% | 138.1% | -537.1% | -0.54 | 0.06 | -2.4 |
| 31 Dec 2016 | FY | 99.7% | -23755.4% | 172.7% | -546.6% | -0.43 | 0.01 | -1.8 |
| -0.8 |
| 30 Sept 2025 | Q3 | 10.4% | -25748.1% | -137.7% | -53.8% | 0.00 | 1.37 | -1.1 |
| 30 Jun 2025 | Q2 | 97.1% | -875.8% | -54.8% | -31.2% | 0.00 | 2.07 | -1.4 |
| 31 Mar 2025 | Q1 | 88.4% | -21359.2% | -86.9% | -51.7% | 0.00 | 2.24 | -0.7 |
| 31 Dec 2024 | Q4 | 92.3% | -3778.6% | -19.2% | -13.3% | 0.00 | 2.97 | -1.7 |
| 30 Sept 2024 | Q3 | 92.2% | -467.2% | -10.9% | -7.5% | 0.00 | 2.95 | -3.2 |
| 30 Jun 2024 | Q2 | 92.7% | -4521.4% | -37.3% | -25.0% | 0.01 | 2.82 | -1.0 |
| 31 Mar 2024 | Q1 | 100.0% | -6352.2% | -15.3% | -12.4% | 0.01 | 4.86 | -1.1 |
| 31 Dec 2023 | Q4 | -121.3% | 6075.5% | 11.7% | 9.3% | 0.02 | 4.37 | 1.7 |